Growth Metrics

Eton Pharmaceuticals (ETON) Free Cash Flow (2018 - 2025)

Eton Pharmaceuticals' Free Cash Flow history spans 7 years, with the latest figure at -$11.6 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 1392.92% to -$11.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.2 million, a 980.7% increase, with the full-year FY2025 number at $10.2 million, up 980.7% from a year prior.
  • Free Cash Flow hit -$11.6 million in Q4 2025 for Eton Pharmaceuticals, down from $11.7 million in the prior quarter.
  • Over the last five years, Free Cash Flow for ETON hit a ceiling of $11.7 million in Q3 2025 and a floor of -$11.6 million in Q4 2025.
  • Historically, Free Cash Flow has averaged $900250.0 across 5 years, with a median of $1.0 million in 2022.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 763.96% in 2022 and later tumbled 1392.92% in 2025.
  • Tracing ETON's Free Cash Flow over 5 years: stood at -$5.1 million in 2021, then surged by 155.22% to $2.8 million in 2022, then crashed by 86.32% to $387000.0 in 2023, then plummeted by 300.78% to -$777000.0 in 2024, then tumbled by 1392.92% to -$11.6 million in 2025.
  • Business Quant data shows Free Cash Flow for ETON at -$11.6 million in Q4 2025, $11.7 million in Q3 2025, and $8.0 million in Q2 2025.